Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an Email Please send an email to stoptrade@acml.in from your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07968101000 Ext: 1 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us, and we appreciate your cooperation in maintaining the integrity of your trading account.
Lijo Chacko is the chief executive officer ' Middle East & Africa at Sigachi Industries. He is a cross-sectoral leader with a rich background spanning defence, industrial manufacturing, and the development sector.
With a proven record in building strategic partnerships, managing complex operations, and driving organizational transformation, Lijo brings a rare blend of experience and insight to the global leadership team at Sigachi.
Lijo is a graduate of the Naval College of Engineering and a certified mountaineer from the Himalayan Mountaineering Institute. He is also an alumnus of Yale University, the Jamnalal Bajaj Institute of Management Studies, the Institute of Development Studies, and the Robert Bosch Foundation. He is a fellow of the Institution of Engineers and a member of the Institute of Directors.
Sigachi Industries is one of the leading manufacturers of Microcrystalline Cellulose (MCC) in the domestic as well as the international market, supplying essential molecules for pharma excipients, nutraceuticals, cosmetics and food industries.
The company's consolidated net profit tanked 11.8% to Rs 13.27 crore on a 23.1% rise in revenue from operations to Rs 128.20 crore in Q4 FY25 over Q4 FY24.
The scrip shed 0.93% to currently trade at Rs 44.61 on the BSE.
Powered by Capital Market - Live News